Oncodesign Precision Medicine Société anonyme

ENXTPA:ALOPM Stock Report

Market Cap: €18.4m

Oncodesign Precision Medicine Société anonyme Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Philippe Genne

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Philippe Genne

no data

Tenure

Dr. Philippe Genne, Ph D., Founded Oncodesign Société Anonyme, serves as its Chairman of the Board and has been its Chief Executive Officer since May 18, 2010 and Chief Corporate Business Development Offic...